Site Search
Search Results
State Senator Devlin Robinson Receives National Distinguished Advocacy Award for Leading the Way on Critical Cancer Legislation
... as a leader and true advocate on cancer advocacy issues,” said Lisa Lacasse, president of ACS CAN. “From advocating for the passage of biomarker legislation in Pennsylvania to sponsoring the Pennsylvania Paid Family & Medical Leave Act, Senator Robinson has tirelessly advocated for ... in Pennsylvania are very fortunate to have an ally like Senator Robinson in the Legislature. Through his work aimed at improving access to biomarker testing and paid family and medical leave, he has shown a singular commitment to reducing the cancer burden for Pennsylvanians. As someone who has ...
Hawai’i Cancer Community Urges State Lawmakers to Defend Medicaid and Expand Colon Cancer Screening Access
... for uninsured and underinsured individuals, including the follow-up colonoscopy required after a positive noninvasive screening test. Biomarker Testing: ACS CAN will continue to advocate for improved coverage of comprehensive biomarker testing which is an important step to accessing precision medicine. This includes targeted therapies that can lead to improved ...
2026 Delaware Cancer Action Day
... (ACS CAN) and the Alzheimer's Association. Join us by sending your lawmakers a message urging them to expand insurance coverage for biomarker testing, so more patients can access the personalized, life-saving treatments they need. 0 2026 Delaware Cancer Action Day ...
2024 West Virginia Legislative Priorities
... for all insurance plans, including traditional Medicaid, to provide a comprehensive benefit for lung cancer screening including all follow-up testing according to recommended guidelines, without enrollee cost sharing or other barriers. Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...
Cancer Advocates Urge Lawmakers to Help Reduce the Cancer Burden on Minnesotans
... coverage options and help Minnesotans facing serious diseases, like cancer, better manage and plan for their prescription drug costs. Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Biomarker testing is an important step to accessing precision medicine that can lead to improved survivorship and better quality ...
Legislative Action Needed to Reduce the Burden of Cancer
... is asking the legislature to prioritize access to care for cancer patients through the expansion of telehealth services and increased access to biomarker testing. Telehealth is critical because it provides cancer patients and survivors with a convenient means of accessing some cancer care and primary ... ‘the right treatment, to the right patient, at the right time,’ precision medicine plays a critical role in improving cancer outcomes, and biomarker testing is an essential step to precision medicine. Legislative action on these pieces of legislation would improve access to care for ...
Courage in Action: Cancer Survivors Unite at State Capitol to Advocate for Change
... home for cancer patients and their caregivers. Advocates also met with lawmakers to ask them to support legislation that would improve access to biomarker testing. This legislation will help address a significant barrier and bring the promise of precision medicine to more Ohioans, no matter their income or where they live. Biomarker testing opens the door to targeted therapies, which can provide many benefits to patients, including better outcomes, improved quality of ...
2025 New Jersey Cancer Action Week
... state leaders to discuss our cancer legislative and budget priorities. Cancer Action Week Legislative Asks: Expand coverage and access to biomarker testing. Pass copay accumulator legislation (S3818/A5217), which would improve access to prescription drugs by ensuring copay assistance is counted ... Maintain funding for the New Jersey Cancer Education and Early Detection Screening Program (NJCEED) at $5 Million. Event Resources: New Jersey Biomarker one pager New Jersey Step Therapy Copay Accumulator New Jersey Commission on Cancer Research New Jersey Cancer Education and Early ...
Maine 2026 Legislative Priorities
... and comprehensive health insurance including Medicaid and will support efforts to curb the availability of inadequate health plans. Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...
2023 Kentucky Legislative Priorities
... products. We will be making the following fact-based policies a priority and ask for your support: Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for House Bill 180, which improves coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...
Type
Priority Issue
State
- New York (35) Apply New York filter
- Ohio (18) Apply Ohio filter
- Pennsylvania (17) Apply Pennsylvania filter
- California (15) Apply California filter
- Washington (15) Apply Washington filter
- Hawaii (13) Apply Hawaii filter
- Maine (13) Apply Maine filter
- New Jersey (13) Apply New Jersey filter
- North Carolina (13) Apply North Carolina filter
- Tennessee (13) Apply Tennessee filter
- Illinois (11) Apply Illinois filter
- Colorado (10) Apply Colorado filter
- Florida (10) Apply Florida filter
- Massachusetts (10) Apply Massachusetts filter
- Connecticut (9) Apply Connecticut filter
- Delaware (9) Apply Delaware filter
- Georgia (8) Apply Georgia filter
- Kentucky (8) Apply Kentucky filter
- Maryland (7) Apply Maryland filter
- National (7) Apply National filter
- Vermont (7) Apply Vermont filter
- Nevada (6) Apply Nevada filter
- New Hampshire (6) Apply New Hampshire filter
- Arizona (5) Apply Arizona filter
- Iowa (5) Apply Iowa filter
- Mississippi (5) Apply Mississippi filter
- Oklahoma (5) Apply Oklahoma filter
- Oregon (5) Apply Oregon filter
- Texas (5) Apply Texas filter
- West Virginia (5) Apply West Virginia filter
- Indiana (4) Apply Indiana filter
- Minnesota (4) Apply Minnesota filter
- New Mexico (4) Apply New Mexico filter
- Nebraska (3) Apply Nebraska filter
- Rhode Island (2) Apply Rhode Island filter
- Alaska (1) Apply Alaska filter
- Louisiana (1) Apply Louisiana filter
- Michigan (1) Apply Michigan filter
- South Dakota (1) Apply South Dakota filter
Policy Issue
- Research, Funding and Drug Development (6) Apply Research, Funding and Drug Development filter
- Access to Health Care (2) Apply Access to Health Care filter
- Eye on Cancer Care (1) Apply Eye on Cancer Care filter
- Health Equity (1) Apply Health Equity filter
- Patient Quality of Life (1) Apply Patient Quality of Life filter